blood bank | The Development of Umbilical Cord Blood Stem Cell Therapy
http://www.cordbloodrecommendation.com Umbilical cord blood is stored immediately after delivery, when the cord is cut. Diseases that are genetically based would most likely be an allogenic transplant. Human umbilical cord blood cells are very rich in stem cells and progenitor cells which make them the perfect place to take cells from and then store them in a cord blood bank or a stem cells bank. Scientists have found that umbilical blood can actually help to treat many types of medical issues. To make a long story short, the Adult Stem Cells did the trick. This would be a significant event, which would save thousands of lives of those waiting for an organ. Why would someone opt for cord blood preservation? Well, research is continually being conducted and cells extracted from this blood has already been used to treat and cure injuries and diseases. Cord Blood Banking facilities are places where you can bank your child #39;s cord blood and use it later on in life to cure life-threatening diseases. The National Cord Blood Program staff at the New York Blood Center performs cord blood collection from the expelled placenta. Because of this amazing capacity of blood cells, they have been, still are and will continue to be used more and more to save lives and cure a number of diseases. ""Umbilical cord blood contains blood-forming cells that can be used to treat life-threatening diseases and conditions. Stem cells, researchers discovered, could cure many diseases such as leukemia and ...From:hotelesenMelgarViews:0 0ratingsTime:01:18More inScience Technology

Originally posted here:
blood bank | The Development of Umbilical Cord Blood Stem Cell Therapy - Video

Recommendation and review posted by simmons

Stem Cells | Stem Cell Malaysia
stemcellmalaysia.com Stem cells are cells which have the potential to develop into virtually any cells of the body. The characteristics of stem cells render them great possibility in treating illness as well as health rejuvenation. Stem cells can repair and renew damaged cells as well as replace the dead ones so that a damaged organ or tissue can be healed to its healthy state. Visit Stem Cell Malaysia at http:/stemcellmalaysia.com/ for more information on stem cells and stem cell therapy.From:stemcells2012Views:262 2ratingsTime:06:33More inHowto Style

The rest is here:
Stem Cells | Stem Cell Malaysia - Video

Recommendation and review posted by simmons

Progenitor Cell Therapy For Neurological Injury
ll4.me Progenitor Cell Therapy For Neurological Injury Preface.- Chapter 1. Basics of Stem and Progenitor Cells.- Chapter 2. Progenitor Cell Tissue Engineering: Scaffold Design and Fabrication.- Chapter 3. Stem Cell Delivery Methods and Routes.- Chapter 4. Neural Stem Cells-Endogenous Repair of Neurological Injury.- Chapter 5. Traumatic Brain Injury: Pathophysiology and Models.- Chapter 6. Traumatic Brain Injury: Relationship of Clinical Injury to Progenitor Cell Therapeutics.- Chapter 7. Cell-Based Therapy for Stroke.- Chapter 8. Spinal Cord Injury: Pathophysiology and Progenitor Cell Therapy.- Chapter 9. Current Status of Clinical Trials using Progenitor Cells for Neurological Injury EAN/ISBN : 9781607619659 Publisher(s): Springer, Berlin, Springer Science Business Media Discussed keywords: Neurologie, Zelltherapie Format: ePub/PDF Author(s): Cox, Charles S. Preface.- Chapter 1. Basics of Stem and Progenitor Cells.- Chapter 2. Progenitor Cell Tissue Engineering: Scaffold Design and Fabrication.- Chapter 3. Stem Cell Delivery Methods and Routes.- Chapter 4From:dorethacopeland98549Views:0 0ratingsTime:00:14More inPeople Blogs

View original post here:
Progenitor Cell Therapy For Neurological Injury - Video

Recommendation and review posted by simmons

25 Multiple Sclerosis Plr Articles
ll4.me 25 Multiple Sclerosis Plr Articles 25 Multiple Sclerosis Articles - Private Label Rights Article Topics:- Treatment For Multiple Sclerosis With No Side Effects Types Of Multiple Sclerosis What Multiple Sclerotic People Should Avoid during Christmas How To Diagnose Multiple Sclerosis How To Know If It Is A Multiple Sclerosis Relapse How To Treat Multiple Sclerosis Is Cannabis Use Beneficial For Multiple Sclerosis Lifesaving Drug For Multiple Sclerosis More Information On Multiple Sclerosis Multiple Sclerosis Association Of America All About Multiple Sclerosis Causes Of Multiple Sclerosis Childbirth May Slow Multiple Sclerosis Common Human Bacteria Triggers Multiple Sclerosis Good News On Pregnancy And Multiple Sclerosis How Is Multiple Sclerosis Classified The Clinical Part Of Multiple Sclerosis The History Of Multiple Sclerosis The Kurtzke Expanded Disability Status Scale And Multiple Sclerosis Multiple Sclerosis Differential Diagnoses Not Everyone With Multiple Sclerosis Is On Treatment Pathophysiology Of Multiple Sclerosis Stem Cell Therapy Reverses Multiple Sclerosis Symptoms Of Multiple Sclerosis Teenage Obesity and Multiple Sclerosis Use the content on : Blogs/Content Pages Report Social Sites ecourses Convert to Audios ebook Bundle and Sell as Products Personal Education, Tips Training Whatever you might imagine... RIGHTS:- [YES] Can Be Sold [YES] Can Be Packaged [YES] Can Be Offered As a Bonus [YES] Can Be Added As Web Content [YES] Can Be Used For Product ...From:rebeccahenson9854Views:0 0ratingsTime:00:14More inPeople Blogs

Excerpt from:
25 Multiple Sclerosis Plr Articles - Video

Recommendation and review posted by simmons

Stem Cell Research and TNG
How close is Science to providing visors for the blind? Or what about curing blindness? Have you watched the episode "The Masterpiece Society" from season 5 of TNG? Cause I have a couple of philosophical things to say about that! An article about STEM CELL therapy in regards to vision impairment: abcnews.go.com Interview with TrekMate: http://www.trekmate.org.uk ***I feel like the Star Trek community is a lot bigger then what YouTube has to offer, so I #39;ve started uploading my own videos. A lot of you will find this painfully dorky -and it is- which is why constructive criticism is welcomed. For anyone who does like my posts, thank you! It would be nice to gather a little Trekkie community :)***From:ThatTrekkieGirlViews:6 1ratingsTime:06:51More inPeople Blogs

Read more here:
Stem Cell Research and TNG - Video

Recommendation and review posted by simmons

Charles - USA Stem Cells Testimonial
If you would like more information please call us Toll Free at 877-578-7908. Or visit our website at http://www.usastemcells.com Or click here to have a Free Phone Constultation with Dr. Matthew Burks usastemcells.com Real patient testimonials for USA Stem Cells. Adult stem cell therapy for COPD, Emphysema, and Pulmonary fibrosis.From:USAStemcellsViews:4 0ratingsTime:10:04More inScience Technology

See more here:
Charles - USA Stem Cells Testimonial - Video

Recommendation and review posted by simmons

Thelma before Stem Cell Therapy
From:krazykp12Views:2 0ratingsTime:01:33More inPeople Blogs

Excerpt from:
Thelma before Stem Cell Therapy - Video

Recommendation and review posted by simmons

SHIMMIAN MANILA - Celebs share good effects of stem cell therapy
From:myrenovatiosolutionsViews:1 0ratingsTime:01:30More inEntertainment

See the original post here:
SHIMMIAN MANILA - Celebs share good effects of stem cell therapy - Video

Recommendation and review posted by simmons

Published on 10 November 2012 Hits: 133 Written by Jovee Marie N. Dela Cruz

The Department of Health (DOH) on Friday said that it has become necessary to issue regulations for stem cell therapy in the country. Health Secretary Enrique Ona said that guidelines for clinics offering stem cell therapy will be released immediately by the DOH and the Food and Drug Administration.

We will issue guidelines because here in the country we dont know where the stem cell offered by clinics come from, he said.

According to the DOH, stem cell therapy belongs to the category of advanced cell therapy, which includes biologics and blood. Many countries apply a risk-based approach to assess the quality, efficacy and safety of advanced cell therapy.

In many countries, stem cell is considered an investigational intervention, Ona said.

The DOH said that stem cell research employs both autologous (from same person) or allogenic (from another organism like an animal or another human cell or tissue sample) method.

Ona said that because there are many steps in the preparation of this lab and invasive procedure, there is a need to have a regulatory framework to protect Filipino citizens.

Read more here:
DOH to regulate stem cell therapy in PH

Recommendation and review posted by simmons

UPDATE on Stem Cell Therapy

7 November 2012

The Department of Health (DOH) saw the necessity to cover regulations for Stem Cell therapy. Stem Cell therapy belongs to the category of Advanced Cell therapy which includes biologics and blood. Many countries around the world apply a risk-based approach to assess the quality, efficacy and safety of advanced cell therapy. In many countries, Stem Cell is considered an investigational intervention.

Stem Cell research employs both autologous (from same person) or allogenic (from another organism like animal or another human cell or tissue sample) method. Because there are many steps in the preparation of this lab and invasive procedure, there is therefore need to have a regulatory framework to protect Filipino citizens.

Important questions were asked: is there proof of concept in animal trials where stem cell can then be applied in humans? Is there a way to ensure quality and purity of the raw materials? How safe is the procedure? How many did not benefit from the procedure? If this were investigational procedure, how will human subjects be protected?

Sec. Enrique Ona convened a consultative working task force to provide recommendations on how to proceed in the early part of the year in response to queries and mushrooming of centers here and overseas. This led to the creation of a regulatory task force to oversee the appropriate steps that will ensure quality, efficacy and safety documentation of this intervention.

Visit link:
UPDATE on Stem Cell Therapy 7 November 2012

Recommendation and review posted by simmons

Whole Genome Sequencing and You
This video is about whole genome sequencing. What is a genome? What are the basics of how whole genome sequencing works? What can you find out about yourself from getting your genome sequenced? And what are the potential benefits and risks? You might be considering getting your genome sequenced for clinical, research or personal reasons. Or you might just be curious and want to learn a bit more about this technology. This video was developed to help you understand a bit more about what whole genome sequencing is, and what it could mean for you. It was developed by researchers at Mount Sinai #39;s Department of Genetics and Genomic Sciences and Department of Emergency Medicine with funding from the Charles Bronfman Institute for Personalized Medicine, with valuable input from several community consultants, patients and others from around the Mount Sinai community. bull; Visit the Department of Genetics and Genomic Sciences: ow.ly bull; Visit the Department of Emergency Medicine: ow.ly bull; Visit the Charles Bronfman Institute for Personalized Medicine: ow.lyFrom:MountSinaiSchoolViews:171 4ratingsTime:10:41More inEducation

See original here:
Whole Genome Sequencing and You - Video

Recommendation and review posted by sam

Computational Challenges and Opportunities in Personalized Medicine
Rapid progress in systems biology and molecular analytical platforms offers the promise of major gains in the detection, treatment and prevention of diseases and for targeting therapeutic interventions to match the molecular and pharmacogenetic profiles of individual patients (personalized medicine). Whole genome sequencing and other molecular diagnostics, next-generation body imaging and miniaturized on-body:in-body sensors will assume increasing importance in the healthcare value chain as powerful platforms for precision diagnosis, selection of optimum treatment, treatment compliance and remote monitoring of individual health status.From:INFORMSonlineViews:4 0ratingsTime:52:39More inScience Technology

Read the original here:
Computational Challenges and Opportunities in Personalized Medicine - Video

Recommendation and review posted by sam

CBI Project Final
Executive summary of Cascade Biotherapeutic, Inc (CBI) product and service offerings to the consumers of healthcare information applyting personalized medicine to managing their health and wellbeing, and government agencies procuring supply chain management solutions for medical countermeasures.From:jcbioteckViews:2 0ratingsTime:03:24More inScience Technology

See the original post here:
CBI Project Final - Video

Recommendation and review posted by sam

CAMBRIDGE, Mass., BOSTON and NEW YORK, Nov. 8, 2012 /PRNewswire/ --GNS Healthcare, Inc. (GNS), the leading healthcare data analytics company focused on enabling personalized medicine to improve human health, today announced that it has entered into a collaboration with Dana-Farber Cancer Institute (Dana-Farber) and Mount Sinai School of Medicine (Mount Sinai) to create a data-driven computer model of multiple myeloma, the second most common blood cancer in the U.S. that constitutes approximately one percent of all cancers. Created using GNS's supercomputer-driven REFS (Reverse Engineering and Forward Simulation) platform, the models will be used to help researchers discover novel therapies for the disease and to help determine the best existing treatments for patients.

"We have made encouraging progress at Dana-Farber Cancer Institute in using gene profiling, proteomic and signaling studies in tumor cell samples treated with existing and novel medicines to get a better understanding of myeloma pathogenesis and to develop novel targeted therapies," said Dr. Ken Anderson, Director, Jerome Lipper Multiple Myeloma Center and LeBow Institute for Myeloma Therapeutics at Dana-Farber and Kraft Family Professor of Medicine at Dana-Farber and Harvard Medical School.

"Because of this progress, our team is excited about deploying a powerful, supercomputer driven approach using our multi-layered genomic data to develop computer models to directly define the integrated underlying circuitry of myeloma. We look forward to using these models to identify, create, and implement better treatments for individual multiple myeloma patients," said Dr. Nikhil Munshi, Associate Director, Jerome Lipper Multiple Myeloma Center and LeBow Institute for Myeloma Therapeutics at Dana-Farber and Associate Professor of Medicine, Harvard Medical School.

"GNS will apply its Big Data analytics platform to create a disease-specific computer model that will yield a powerful new resource to the multiple myeloma research and clinical communitywith the ultimate aim of better outcomes for patients," said GNS CEO and co-founder Colin Hill. "This collaboration with Dana-Farber and Mount Sinai will create models that will help transform the tremendous amount of data coming from new technologies, such as next-generation sequencing, into predictive computer models of disease progression and treatment response for scientists and clinicians. This project is one of many examples of our work in challenging, complex and, sometimes rare, diseases."

In this collaboration, GNS will employ the REFSplatform to reverse engineer network models from next-generation genetic sequencing, proteomic, outcomes and other clinical data. Results from millions ofin silico simulations of the REFS models will provide new insights into the fundamental mechanisms of multiple myeloma, enabling the identification of novel intervention points in the disease for specific groups of patients and the development of more effective medicines.

"Prior published work has shown us that approaches like the REFS platform can develop integrated network models of disease that can be used to uncover novel drivers of disease," said Dr. Eric Schadt, Director of the Institute for Genomics and Multiscale Biology, Chair of the Department of Genetics and Genomics Sciences and the Jean C. and James W. Crystal Professor of Genomics at Mount Sinai. "With the wealth of detailed biological data available in this project, we look forward to a close collaboration with GNS to build a predictive model to elucidate novel insights into this complex disease."

About Multiple Myeloma

Multiple myeloma is a cancer of plasma cells, a type of white blood cell normally responsible for producing antibodies. In multiple myeloma, collections of abnormal plasma cells accumulate in the bone marrow, where they interfere with the production of normal blood cells. Most cases of myeloma also feature the production of a paraproteinan abnormal antibody which can cause kidney problems. Bone lesions and hypercalcemia (high calcium levels) are also often encountered. Myeloma is diagnosed with blood tests (serum protein electrophoresis, serum free kappa/lambda light chain assay), bone marrow examination, urine protein electrophoresis and X-rays of commonly involved bones. Myeloma is generally thought to be treatable but incurable. Remissions may be induced with steroids, chemotherapy, proteasome inhibitors (e.g. bortezomib), immunomodulatory drugs (IMiDs) such as thalidomide or lenalidomide and stem cell transplants. Radiation therapy is sometimes used to reduce pain from bone lesions. Myeloma develops in 1-4 per 100,000 people per year. It is more common in men, and for unknown reasons is twice as common in African-Americans as it is in white Americans. With conventional treatment, median survival is 3-4 years, which may be extended to 5-7 years or longer with advanced treatments. Multiple myeloma is the second most common hematological malignancy in the U.S. (after non-Hodgkin lymphoma) and constitutes 1 percent of all cancers.

About REFS

REFS (Reverse Engineering and Forward Simulation) is GNS Healthcare's scalable, supercomputer-enabled framework for discovering new knowledge directly from data. REFS automates the discovery and extraction of causal network models from observational data and uses high-throughput simulations to generate new knowledge.

See the original post here:
GNS Healthcare, Dana-Farber and Mount Sinai Collaborate to Build Computer Model of Multiple Myeloma

Recommendation and review posted by sam

Ignyta, Inc., the personalized medicine company dedicated to improving the diagnosis and treatment of patients with rheumatoid arthritis, lupus and other autoimmune diseases, will present two of its scientific research studies during the American College of Rheumatology (ACR) Annual Meeting, Nov. 10 to 14, in Washington DC. Both presentations reflect Ignytas scientific emphasis on epigenetic mechanisms of autoimmune diseases.

San Diego, CA (PRWEB) November 09, 2012

An oral presentation entitled The DNA Methylation Signature in Fibroblast-Like Synoviocytes (FLS) Defines Critical Pathogenic Pathways in Rheumatoid Arthritis (RA), will be delivered on Monday, Nov.12 at 2:30 p.m. by Gary Firestein, M.D., Director of the Clinical and Translational Research Institute, Dean and Associate Vice Chancellor of Translational Medicine at UCSD, and Ignyta co-founder. Ignyta scientists are listed as co-authors on the presentation.

Ignytas Chief Scientific Officer, David Anderson, Ph.D., will present a poster entitled "The DNA Methylome of Systemic Lupus Erythematosus (SLE) From Whole Peripheral Blood Mononuclear Cells (PBMCs)," during the session on Systemic Lupus Erythematosus - Human Etiology and Pathogenesis, on Tuesday, Nov. 13 from 9 a.m. - 6 p.m.

The selection by ACR of two Ignyta presentations reflects the importance of the work that Ignyta is contributing to the rheumatology field, said Jonathan Lim, M.D., CEO of Ignyta, Inc. Ignyta continues to make rapid progress in advancing novel biomarkers and molecular diagnostics for rheumatoid arthritis and systemic lupus erythematosus.

The Ignyta poster will be available for download on Monday, Nov. 12 at http://ignyta.com/nexdx_scientific_presentations.php.

Both presentations reflect Ignytas scientific emphasis on epigenetic mechanisms. Within cells, the DNA signatures caused by methylation, a dominant epigenetic regulator, are potentially a novel and important source of biomarkers to better diagnose RA and other autoimmune diseases for the following reasons:

Epigenetic mechanisms recently have been shown to have a significant impact on several human diseases, including RA and systemic lupus erythematosus. Because aberrant DNA methylation might play an important role in the pathogenesis of RA, DNA methylation signatures could be developed as a valuable diagnostic tool.

These signatures are a more chemically and biologically stable source of molecular diagnostic information than RNA and many proteins, and reflect past environmental conditions leading to persistent changes in how cells transcribe their genome, leading to the expression of genes and their protein products.

The prevalence of DNA methylation biomarkers is higher than most genetic markers of disease and can be associated with multiple sites within a cell, potentially affecting several genes or other regulatory molecules. These biomarkers can be detected with very high sensitivity and specificity in blood-based tests, serving as tools for diagnosing diseases, as well as assessing patients' prognoses and personalized responses to therapy.

The rest is here:
Ignyta Announces Scientific Presentations at American College of Rheumatology 2012 Annual Meeting

Recommendation and review posted by sam

CHALFONT, Pa., Nov. 8, 2012 (GLOBE NEWSWIRE) -- Genomind, a personalized medicine company for neuropsychiatry, is excited to announce that company representatives will be attending and exhibiting at the American Psychiatric Nurses Association Annual Conference and the U.S. Psychiatric and Mental Health Congress, two respected conventions of mental health professionals that will occur this week.

Genomind will be on hand to share the most recent research and advancements in the field of personalized medicine, including their groundbreaking GeneceptTM Assay, a saliva-based test that quickly identifies biomarkers and genes that may influence or assist a clinician in developing a treatment plan for patients with depression and other neurological disorders. Genomind staff will share information with attendees on how such tests can be implemented into their practices, as well as how use of the test can often lead to better patient outcomes.

The American Psychiatric Nurses Association Annual Conference runs from November 7-10, 2012, at the David L. Lawrence Convention Center in Pittsburgh. The U.S. Psychiatric and Mental Health Congress will take place November 8-11, 2012, at the San Diego Convention Center.

About the Genecept Assay

The Genecept Assay is a comprehensive, simple-to-use tool for understanding genetic and biological markers that best inform response to different psychiatric treatments. The Assay is Genomind's core product, and contains a proprietary panel of biomarker tests, an analytic report, and a psychopharmacologist consultation. The Assay can be used for a range of psychiatric conditions including depression, bipolar disorder, schizophrenia, anxiety disorders, OCD and ADHD. For more information on the Assay, including information about the specific genes in the panel, please visit http://www.genomind.com/products/assay.

About Genomind

Genomind is a personalized medicine company, comprised of innovative researchers and expert leaders in psychiatry and neurology. Genomind is committed to discovery of the underlying causes of neuropsychiatric disorders and supports the development of personalized medicine that improves patients' lives. Genomind was founded by Ronald I. Dozoretz, MD, a psychiatrist who has devoted his career to improving mental health. Jay Lombard, DO, a neurologist and co-founder of Genomind, is a critically acclaimed author and nationally recognized thought leader in neuropsychiatry practice and research. Learn more at http://www.genomind.com.

For more information, contact:

Doreen Korba Director of Marketing 215.396.5596 Doreen.Korba@genomind.com

This information was brought to you by Cision http://www.cisionwire.com http://www.cisionwire.com/genomind/r/genomind-to-exhibit-at-two-upcoming-mental-health-conferences,c9331955

Excerpt from:
Genomind to Exhibit at Two Upcoming Mental Health Conferences

Recommendation and review posted by sam

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/jm477c/personalized) has announced the addition of the "Personalized Medicine Partnering Terms and Agreements" report to their offering.

Comprehensive understanding and unprecedented access to the personalized medicine partnering deals and agreements entered into by the worlds leading healthcare companies.

The Personalized Medicine Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the personalized medicine partnering deals and agreements entered into by the worlds leading healthcare companies.

The report provides a detailed understanding and analysis of how and why companies enter personalized medicine partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors personalized medicine technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases do not.

This report contains over 1500 links to online copies of actual personalized medicine deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners. Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.

Report scope

Personalized Medicine Partnering Terms and Agreements is intended to provide the reader with an in-depth understanding and access to personalized medicine trends and structure of deals entered into by leading companies worldwide.

Personalized Medicine Partnering Terms and Agreements includes:

See the article here:
Research and Markets: Personalized Medicine Partnering Terms and Agreements

Recommendation and review posted by sam

God of AfricaBluewale Creations xvid
Grace Jerry is a sensational multi talented Gospel singer based in Jos. Despite an accident that caused her a spinal cord injury and has forced her to use a wheel chair for some years now, she has not allowed that to diminish her passion and love for God and for music. She flies her wings of creativity and music in diverse ways, she #39;s a WASH Ambassador with Water Aid, Motivational Speaker, Mentor, Life Coach and Children Teacher.From:bluewalecreationsViews:2 0ratingsTime:14:11More inEntertainment

Read the original:
God of AfricaBluewale Creations xvid - Video

Recommendation and review posted by sam

walk with us
SPECIAL THANKS TO: USAID, LRI, LE ROYAL, BECHARE MUNICIPALITY AND SCHOOLS, FRIENDS OF THE CEDARS AND ALL THE HUNDREDS OF PEOPLE WHO WALKED WITH US. November 3, 2012- "Let Your Disability Be Your Power" was the motto of Micheal Haddad #39;s walk in the Cedars forest as an initiative of "Walk for Cedars". Mr. Haddad is a disabled from the chest down due to a spinal cord injury. He conducted his walk despite his disability making his steps hard and almost impossible to do. He fought, held out and walked 5000 steps for 5000 Cedar trees in return in order to aware the national society on the importance of protecting and maintaining the Lebanese environment. This event was a special launching to a reforestation campaign sponsored by the NGO SHIELD and a forestation project in Lebanon closely supported by the Friends of Cedar Forest Committee in Bchare and the municipality of Bchare. "Walk for Cedars" is an initiative launched by Micheal Haddad to aware the society on more than 250 thousand disabled people in Lebanon (app. 7% of Lebanon #39;s population) who need to be rehabilitated and reintegrated in the society as active and productive citizens. For, they got the power to turn their disability into ability despite their handicap. So did Micheal Haddad establish SHIELD, an NGO that supports the Walk along with the forestation project in Lebanon LIR (Lebanon Reforestation Initiative). This project is funded by the financing program of the United States Agency for the International ...From:Elias El MokdessiViews:2 1ratingsTime:02:57More inPeople Blogs

More:
walk with us - Video

Recommendation and review posted by sam

Brain and Spinal Cord Injury PSA
From:fldohViews:0 0ratingsTime:00:31More inEducation

See the original post here:
Brain and Spinal Cord Injury PSA - Video

Recommendation and review posted by sam

What #39;s in-possible is so possible!
I was told 29 years ago that it would not be possible for me to father a child due to a spinal cord injury that left me paralyzed from the T5-6 level, complete. The truth is that even with a spinal cord injury you can father a child. Thing is, depending on the location of your injury you can have a child as easily as a non-spinal cord/paralyzed male or it may take newer methods of insemination. It #39;s just about information. See my website for more details or just ask me here on YT.From:AstonnMartin2003Views:0 0ratingsTime:02:56More inEducation

Read more:
What's in-possible is so possible! - Video

Recommendation and review posted by sam

cryocell | Why Store Your Cord Blood In a Bank?
http://www.cordbloodrecommendation.com A large number of people die waiting for a transplant due to this reason. Before any blood donations are made it is important for a pregnant mother interested to make the donation to contact the bank before the thirty fourth week of her pregnancy. However, private banking is generally not recommended unless there is a family history of specific genetic diseases. It contains stem cells that have been found to be excellent for research and treatment of many diseases. A man can change his god-gifted features wishfully with the help of science. Given the progress that stem cell research and regenerative medicine have attained at present, and the promise that they show for the future, stem cell transplants may one day provide a cure for type 1 diabetes, heart disease, and brain injury, among other potentially life threatening and debilitating illnesses and conditions with inadequate treatment options today. One study in particular by Wagner, et al. ""Settling on a name for your newborn is definitely something all parents spend time doing, but one decision that is rarely thought of or overlooked is saving your newborn #39;s cord blood. The mother will be informed about the status of the blood unit and the test results so that she is aware of any infection or disease that might affect her baby. Many parents see placental and cord blood banking as valuable tools to help them secure potentially lifesaving treatment options their families may some day ...From:loshoteles enmedellinViews:1 0ratingsTime:01:18More inScience Technology

Read the original here:
cryocell | Why Store Your Cord Blood In a Bank? - Video

Recommendation and review posted by sam

Will Human Growth Hormone (HGH) Affect Fertility?
MetroMD.net Human Growth Hormone (HGH) Replacement is a popular therapy that is effective in reversing the signs and symptoms of aging. Among it #39;s many benefits, HGH increases libido in many patients. But we are often asked about HGH #39;s effect on fertility for both men and women. Dr. Martin addresses these concerns in this brief video presentation. For more info, visit us at http or call (323) 285-5300. The MetroMD Institute of Regenerative Medicine is located in Hollywood at the heart of Los Angeles.From:MetroMDViews:3 0ratingsTime:02:09More inScience Technology

More:
Will Human Growth Hormone (HGH) Affect Fertility? - Video

Recommendation and review posted by sam

Improve Your Cholesterol with Human Growth Hormone (HGH)
MetroMD.net Did you know that you can improve your cholesterol with HGH? Human Growth Hormone Replacement is a popular therapy that is effective in reversing the signs and symptoms of aging. One of the lesser-known benefits is that HGH can actually improve your blood profile and reduce the risk of heart disease. Dr. Alex Martin MD explains how and why in this brief video presentation. For more info, visit us at MetroMD.net or call (323) 285-5300. The MetroMD Institute of Regenerative Medicine is located in Hollywood at the heart of Los Angeles.From:MetroMDViews:0 0ratingsTime:01:54More inScience Technology

Read more:
Improve Your Cholesterol with Human Growth Hormone (HGH) - Video

Recommendation and review posted by sam

ALAMEDA, Calif.--(BUSINESS WIRE)--

BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today reported financial results for the third quarter and year-to-date period ended September 30, 2012 and highlighted recent corporate accomplishments.

Financial Results

Net Loss

Net loss attributable to BioTime for the third quarter of 2012 was $5.0 million or $0.10 per share, compared to a net loss of $3.7 million or $0.08 per share for the same period of 2011. For the nine months ended September 30, 2012, net loss attributable to BioTime was $15.4 million, or $0.31 per share, compared to $11.2 million, or $0.23 per share for the same period of 2011.

Revenue

Total revenue, on a consolidated basis, was approximately $1.0 million and $2.7 million for the third quarter and year-to-date period ended September 30, 2012, respectively, compared to $1.2 million and $2.8 million for the same periods of 2011. Total revenue was effectively the same as prior periods, but license revenue increased based upon our subsidiary LifeMap Sciences subscription and advertising revenue for GeneCards, which was offset by lower grant revenue recognized due to the completion of the California Institute of Regenerative Medicine (CIRM) grant in August 2012.

Expenses

Total operating expenses for the third quarter of 2012 were $6.8 million, compared to $5.4 million for the comparable period in 2011. Research and development expenses for the second quarter of 2012 were $4.6 million, compared to $3.5 million for the comparable 2011 period. General and administrative expenses for the third quarter of 2012 were $2.2 million, compared to $1.9 million for the comparable 2011 period.

Total operating expenses for the first nine months of 2012 were $20.4 million, compared to $15.9 million for the comparable period in 2011. Research and development expenses for the first nine months of 2012 were $13.3 million, compared to $9.8 million for the comparable 2011 period. General and administrative expenses for the first nine months of 2012 were $7.0 million, compared to $6.2 million for the comparable 2011 period.

More:
BioTime Announces Third Quarter 2012 Financial Results and Recent Corporate Accomplishments

Recommendation and review posted by sam